BIOFIL CHEMICALS & PHARMACEUTICALS LTD. - Submission Of Un-Audited Financial Result And Limited Review Report Thereon For The Quarter Ended On 30Th June, 2022.

This is in continuation of our letter dated 2nd August, 2022 regarding information of Board Meeting for consideration and approval of un-audited Financial Results for the quarter ended on 30th June, 2022. Pursuant to the provisions of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we are pleased to submit the Un-audited Financial Results together with Limited Review Report thereon for the quarter ended 30th June 2022 duly approved by the Board of Directors of the Company at its meeting held today i.e. on Tuesday, 9th August, 2022 at the Registered office of the Company. Copy of Unaudited Financial Results along with Limited Review Report is enclosed with this letter (searchable PDF mode). Further, copy of Un-Audited Financial Statements shall also be submitted in XBRL mode within 24 hours from the conclusion of Board Meeting.